WebJan 4, 2024 · Novartis Gene Therapies’ Libertyville, Ill., plant, which produces Zolgensma — the world’s most expensive drug at more than $2.1 million per treatment — has drawn a Form 483 with five observations during a June 8-16 inspection by the FDA. In their first observation, the agency investigators noted an out-of-specification (OOS) result for a … WebPharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing Printer Friendly View Address: 1940 USG Dr Libertyville, IL, 60048-5346 United States See other …
Novartis to lay off 275 workers in Libertyville with closure of plant
WebNovartis has announced the renaming of its previously acquired AveXis gene therapy arm because of “the growing importance of gene therapy to building a leading, focused medicines company with advanced therapy platforms.” AveXis, headquartered in Bannockburn, Illinois, was purchased in 2024 for $8.7 billion by the Swiss drugmaker … WebJan 10, 2024 · “The new site will be manufacturing gene therapies for rare genetic diseases, including our FDA-approved gene therapy for the treatment of spinal muscular atrophy (SMA) [Zolgensma],” Novartis spokesperson Anja von Treskow told this publication. hockey wings
Novartis cuts 275 jobs at its IL plant - BioProduction
WebSince 2013, Novartis Gene Therapies (formerly AveXis) has had one focus: bringing change to those devastated by genetic diseases. Gene therapy manufacturing Novartis Gene … WebNovartis Gene Therapies 5 years 11 months Quality Information Technology Senior Specialist ... Libertyville, Illinois, United States · Lead SME for Quality Control Product Specifications, Sample ... WebNov 5, 2024 · Swiss pharmaceutical company Novartis announced it will be closing its gene therapy manufacturing facility in Libertyville in a move that will affect about 275 workers. hockeywinnipeg.ca